Pediatric Hyperhidrosis: Diagnosis, Impact, and Treatment Options

Conclusions

• Primary focal hyperhidrosis appears to be a common autonomic dysfunction that often begins in childhood and can significantly impair quality of life, self-confidence, and school functioning.
• Children and adolescents may present with different and sometimes broader sweating patterns than adults, with palms, soles, axillae, and multiple focal regions commonly involved.
• Diagnosis is usually clinical, relying mainly on history and physical examination rather than extensive laboratory workup unless another cause is suspected.
• Hyperhidrosis is frequently underrecognized and undertaught, so better clinician awareness is needed to identify and treat affected patients earlier.
• Family history and genetic factors seem to contribute to hyperhidrosis, although the exact mechanisms remain incompletely understood.
• Limited but meaningful treatments are available for pediatric patients, including topical antiperspirants, oral anticholinergics, iontophoresis, and newer FDA-approved topical options.
• Oral glycopyrrolate and oxybutynin can be effective in children, with most adverse effects being anticholinergic and generally manageable.
• Topical glycopyrronium tosylate and sofpironium gel provide effective newer options for axillary hyperhidrosis with minimal systemic exposure.
• Treatment should be individualized to the child’s age, sweat distribution, symptom severity, and practical issues such as access and insurance coverage.
• Clinicians should also consider associated conditions such as dysautonomia and Ehlers-Danlos syndrome when patients with hyperhidrosis have flushing, fainting, or joint hypermobility.
• Patient and family education resources like SweatHelp.org and attention to supportive care can improve access to treatment and overall management.
• Pediatric hyperhidrosis is best approached seriously because even when medically benign, it can be socially isolating and developmentally impactful.